|
Video: What is a Stock Split?
|
|
Lucira Health is a medical technology company focused on the development and commercialization of infectious disease test kits. Co. has developed a testing platform that produces molecular testing in a single-use test kit that is powered by two AA batteries and fits in the palm of a hand. Co.'s primary commercially available polymerase chain reaction-quality diagnostic test is the LUCIRA COVID-19 All-In-One Test Kit. According to our LHDX stock split history records, LHDX has had 0 splits. | |
|
LHDX (LHDX) has 0 splits in our LHDX stock split history database.
Looking at the LHDX stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into LHDX shares, starting with a $10,000 purchase of LHDX, presented on a split-history-adjusted basis factoring in the complete LHDX stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/08/2021 |
|
End date: |
03/03/2023 |
|
Start price/share: |
$28.89 |
|
End price/share: |
$0.45 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.44% |
|
Average Annual Total Return: |
-86.67% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$156.50 |
|
Years: |
2.06 |
|
|
|
|
|